| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| African Americans | 186 | 2021 | 1424 | 22.070 |
Why?
|
| Kidney Failure, Chronic | 116 | 2020 | 543 | 18.900 |
Why?
|
| Diabetes Mellitus, Type 2 | 167 | 2020 | 1428 | 18.850 |
Why?
|
| Apolipoproteins | 50 | 2019 | 200 | 14.290 |
Why?
|
| Diabetic Nephropathies | 71 | 2020 | 224 | 13.780 |
Why?
|
| Lipoproteins, HDL | 48 | 2018 | 251 | 13.430 |
Why?
|
| Genetic Predisposition to Disease | 153 | 2021 | 835 | 11.930 |
Why?
|
| Renal Insufficiency, Chronic | 44 | 2020 | 291 | 10.870 |
Why?
|
| Polymorphism, Single Nucleotide | 152 | 2021 | 1062 | 10.620 |
Why?
|
| Kidney Diseases | 36 | 2019 | 249 | 10.550 |
Why?
|
| Albuminuria | 45 | 2020 | 181 | 7.590 |
Why?
|
| Humans | 436 | 2021 | 32082 | 5.880 |
Why?
|
| Renal Dialysis | 30 | 2019 | 282 | 5.810 |
Why?
|
| European Continental Ancestry Group | 99 | 2019 | 1165 | 5.750 |
Why?
|
| Middle Aged | 251 | 2021 | 11834 | 5.270 |
Why?
|
| Genotype | 94 | 2021 | 733 | 5.250 |
Why?
|
| Molecular Motor Proteins | 26 | 2015 | 58 | 5.040 |
Why?
|
| Myosin Heavy Chains | 26 | 2015 | 89 | 4.980 |
Why?
|
| Hypertension | 50 | 2020 | 961 | 4.810 |
Why?
|
| Genome-Wide Association Study | 70 | 2021 | 547 | 4.710 |
Why?
|
| Male | 281 | 2021 | 19202 | 4.680 |
Why?
|
| Kidney Transplantation | 18 | 2020 | 517 | 4.660 |
Why?
|
| Cardiovascular Diseases | 45 | 2019 | 1128 | 4.650 |
Why?
|
| Female | 284 | 2021 | 19999 | 4.650 |
Why?
|
| Glomerular Filtration Rate | 46 | 2020 | 308 | 4.520 |
Why?
|
| Bone Density | 14 | 2018 | 205 | 4.110 |
Why?
|
| Genetic Variation | 31 | 2020 | 244 | 3.910 |
Why?
|
| Risk Factors | 102 | 2020 | 3880 | 3.800 |
Why?
|
| Aged | 178 | 2020 | 10308 | 3.750 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 14 | 2019 | 38 | 3.090 |
Why?
|
| Atherosclerosis | 19 | 2019 | 766 | 3.020 |
Why?
|
| African Continental Ancestry Group | 32 | 2021 | 363 | 2.940 |
Why?
|
| Kidney | 19 | 2020 | 518 | 2.820 |
Why?
|
| Calcinosis | 17 | 2016 | 146 | 2.710 |
Why?
|
| Lupus Erythematosus, Systemic | 26 | 2018 | 148 | 2.700 |
Why?
|
| Graft Survival | 9 | 2020 | 313 | 2.690 |
Why?
|
| Cognition Disorders | 12 | 2018 | 385 | 2.690 |
Why?
|
| Adult | 131 | 2020 | 9375 | 2.630 |
Why?
|
| Serum Albumin | 9 | 2018 | 54 | 2.630 |
Why?
|
| Brain | 15 | 2019 | 948 | 2.600 |
Why?
|
| Case-Control Studies | 60 | 2018 | 895 | 2.540 |
Why?
|
| Coronary Artery Disease | 19 | 2018 | 401 | 2.530 |
Why?
|
| Disease Progression | 28 | 2020 | 594 | 2.460 |
Why?
|
| Blood Pressure | 23 | 2020 | 846 | 2.190 |
Why?
|
| Continental Population Groups | 18 | 2019 | 237 | 2.180 |
Why?
|
| Lupus Nephritis | 10 | 2019 | 30 | 2.170 |
Why?
|
| Adipose Tissue | 11 | 2018 | 349 | 2.150 |
Why?
|
| Tissue Donors | 9 | 2019 | 198 | 1.980 |
Why?
|
| Haplotypes | 48 | 2019 | 220 | 1.940 |
Why?
|
| Blood Glucose | 13 | 2018 | 494 | 1.890 |
Why?
|
| Diabetes Complications | 16 | 2018 | 177 | 1.890 |
Why?
|
| JC Virus | 5 | 2019 | 20 | 1.880 |
Why?
|
| Vitamin D | 6 | 2018 | 184 | 1.860 |
Why?
|
| Living Donors | 4 | 2020 | 64 | 1.790 |
Why?
|
| United States | 48 | 2020 | 3975 | 1.780 |
Why?
|
| Linkage Disequilibrium | 30 | 2019 | 185 | 1.770 |
Why?
|
| Genetic Testing | 9 | 2020 | 96 | 1.760 |
Why?
|
| Alleles | 37 | 2019 | 248 | 1.750 |
Why?
|
| Phenotype | 40 | 2020 | 632 | 1.740 |
Why?
|
| Genetic Loci | 17 | 2021 | 146 | 1.740 |
Why?
|
| Cognition | 10 | 2019 | 556 | 1.630 |
Why?
|
| Diabetes Mellitus | 13 | 2019 | 412 | 1.620 |
Why?
|
| Adiposity | 8 | 2018 | 198 | 1.570 |
Why?
|
| Tumor Virus Infections | 3 | 2018 | 21 | 1.540 |
Why?
|
| Polyomavirus Infections | 3 | 2018 | 21 | 1.530 |
Why?
|
| Diabetic Angiopathies | 15 | 2017 | 143 | 1.530 |
Why?
|
| Genetic Association Studies | 22 | 2021 | 146 | 1.510 |
Why?
|
| Cross-Sectional Studies | 28 | 2018 | 1542 | 1.490 |
Why?
|
| Carotid Artery Diseases | 10 | 2016 | 114 | 1.470 |
Why?
|
| Body Mass Index | 22 | 2018 | 923 | 1.450 |
Why?
|
| Cohort Studies | 43 | 2019 | 1816 | 1.370 |
Why?
|
| Obesity | 15 | 2018 | 1176 | 1.340 |
Why?
|
| Genome, Human | 17 | 2020 | 132 | 1.330 |
Why?
|
| Glomerulonephritis | 4 | 2018 | 21 | 1.320 |
Why?
|
| Chromosome Mapping | 26 | 2019 | 193 | 1.310 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 3 | 2018 | 5 | 1.300 |
Why?
|
| Fibroblast Growth Factors | 4 | 2018 | 35 | 1.290 |
Why?
|
| Acetyl-CoA Carboxylase | 5 | 2013 | 23 | 1.280 |
Why?
|
| DNA | 9 | 2018 | 226 | 1.270 |
Why?
|
| Gene Frequency | 36 | 2018 | 220 | 1.270 |
Why?
|
| Coronary Vessels | 10 | 2018 | 165 | 1.260 |
Why?
|
| Arteriovenous Shunt, Surgical | 4 | 2017 | 48 | 1.250 |
Why?
|
| Creatinine | 17 | 2020 | 196 | 1.160 |
Why?
|
| Polymorphism, Genetic | 14 | 2018 | 184 | 1.140 |
Why?
|
| Risk Assessment | 24 | 2020 | 1427 | 1.140 |
Why?
|
| Prognosis | 21 | 2019 | 1496 | 1.120 |
Why?
|
| Membrane Proteins | 10 | 2019 | 256 | 1.110 |
Why?
|
| Galvanic Skin Response | 3 | 2016 | 3 | 1.110 |
Why?
|
| Donor Selection | 4 | 2020 | 33 | 1.080 |
Why?
|
| Organ Size | 7 | 2018 | 218 | 1.070 |
Why?
|
| Hypertension, Renal | 7 | 2015 | 29 | 1.070 |
Why?
|
| Antihypertensive Agents | 15 | 2020 | 352 | 1.050 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2018 | 1325 | 1.050 |
Why?
|
| Catheterization, Central Venous | 3 | 2017 | 62 | 1.030 |
Why?
|
| Osteoporosis | 2 | 2018 | 70 | 1.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2017 | 251 | 1.000 |
Why?
|
| Stroke | 4 | 2019 | 584 | 0.970 |
Why?
|
| Proteinuria | 7 | 2019 | 59 | 0.960 |
Why?
|
| Kidney Glomerulus | 3 | 2014 | 30 | 0.950 |
Why?
|
| Caveolin 1 | 2 | 2015 | 13 | 0.950 |
Why?
|
| Tomography, X-Ray Computed | 17 | 2019 | 917 | 0.930 |
Why?
|
| Epistasis, Genetic | 7 | 2018 | 44 | 0.930 |
Why?
|
| Hispanic Americans | 22 | 2019 | 940 | 0.920 |
Why?
|
| Adiponectin | 6 | 2017 | 106 | 0.910 |
Why?
|
| C-Reactive Protein | 7 | 2018 | 238 | 0.910 |
Why?
|
| Gene Expression Regulation | 12 | 2021 | 493 | 0.880 |
Why?
|
| Kidney Function Tests | 9 | 2019 | 107 | 0.880 |
Why?
|
| Renal Insufficiency | 4 | 2019 | 58 | 0.870 |
Why?
|
| Aged, 80 and over | 35 | 2020 | 3990 | 0.830 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2020 | 73 | 0.820 |
Why?
|
| Mutation | 4 | 2018 | 485 | 0.800 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 71 | 0.790 |
Why?
|
| Tissue and Organ Procurement | 4 | 2019 | 93 | 0.790 |
Why?
|
| Hospitalization | 3 | 2020 | 468 | 0.790 |
Why?
|
| Indians, North American | 7 | 2016 | 109 | 0.780 |
Why?
|
| Treatment Outcome | 21 | 2020 | 3304 | 0.780 |
Why?
|
| North Carolina | 17 | 2019 | 1538 | 0.780 |
Why?
|
| Ethnic Groups | 11 | 2017 | 476 | 0.780 |
Why?
|
| Psoas Muscles | 2 | 2019 | 19 | 0.770 |
Why?
|
| Incidence | 15 | 2018 | 1199 | 0.770 |
Why?
|
| Risk | 11 | 2020 | 321 | 0.760 |
Why?
|
| Nephrosclerosis | 2 | 2019 | 4 | 0.750 |
Why?
|
| Sickle Cell Trait | 2 | 2011 | 14 | 0.740 |
Why?
|
| Young Adult | 23 | 2019 | 2665 | 0.730 |
Why?
|
| Insulin | 7 | 2018 | 367 | 0.730 |
Why?
|
| Quantitative Trait Loci | 9 | 2019 | 140 | 0.730 |
Why?
|
| Blood Pressure Determination | 7 | 2020 | 100 | 0.730 |
Why?
|
| Proportional Hazards Models | 12 | 2019 | 753 | 0.730 |
Why?
|
| Prevalence | 15 | 2019 | 989 | 0.720 |
Why?
|
| Lipids | 5 | 2021 | 232 | 0.710 |
Why?
|
| Pericardium | 3 | 2010 | 52 | 0.710 |
Why?
|
| Pre-Eclampsia | 2 | 2012 | 66 | 0.700 |
Why?
|
| Time Factors | 14 | 2018 | 2145 | 0.700 |
Why?
|
| Spine | 2 | 2018 | 41 | 0.690 |
Why?
|
| AIDS-Associated Nephropathy | 6 | 2015 | 11 | 0.690 |
Why?
|
| Vascular Resistance | 1 | 2019 | 31 | 0.690 |
Why?
|
| Cerebrovascular Circulation | 2 | 2019 | 93 | 0.690 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2019 | 30 | 0.690 |
Why?
|
| Models, Genetic | 7 | 2020 | 94 | 0.690 |
Why?
|
| Pedigree | 13 | 2018 | 140 | 0.690 |
Why?
|
| Nephritis | 4 | 2015 | 15 | 0.690 |
Why?
|
| Follow-Up Studies | 17 | 2018 | 2263 | 0.690 |
Why?
|
| Parathyroid Hormone | 2 | 2018 | 45 | 0.680 |
Why?
|
| Animals | 30 | 2019 | 7510 | 0.670 |
Why?
|
| Registries | 3 | 2016 | 298 | 0.660 |
Why?
|
| Urinary Tract Infections | 2 | 2019 | 45 | 0.660 |
Why?
|
| Urine | 2 | 2019 | 65 | 0.660 |
Why?
|
| Cerebral Hemorrhage | 1 | 2019 | 68 | 0.660 |
Why?
|
| Family Health | 11 | 2013 | 78 | 0.660 |
Why?
|
| Sweat Glands | 2 | 2016 | 2 | 0.650 |
Why?
|
| Insulin Resistance | 14 | 2017 | 461 | 0.650 |
Why?
|
| Apolipoproteins E | 3 | 2016 | 95 | 0.630 |
Why?
|
| Mass Screening | 5 | 2009 | 263 | 0.610 |
Why?
|
| Biological Products | 1 | 2019 | 77 | 0.610 |
Why?
|
| Sepsis | 1 | 2019 | 161 | 0.610 |
Why?
|
| Medicaid | 2 | 2017 | 94 | 0.610 |
Why?
|
| Receptors, Cell Surface | 2 | 2016 | 70 | 0.610 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 684 | 0.600 |
Why?
|
| Brain Ischemia | 1 | 2019 | 146 | 0.600 |
Why?
|
| Spinal Fractures | 1 | 2018 | 43 | 0.600 |
Why?
|
| Nerve Tissue Proteins | 4 | 2021 | 118 | 0.600 |
Why?
|
| RNA, Messenger | 5 | 2016 | 507 | 0.590 |
Why?
|
| Heart | 3 | 2009 | 176 | 0.590 |
Why?
|
| Aortic Diseases | 2 | 2016 | 63 | 0.590 |
Why?
|
| Chemokine CCL2 | 2 | 2020 | 48 | 0.590 |
Why?
|
| Neuropsychological Tests | 7 | 2018 | 371 | 0.570 |
Why?
|
| Mitochondrial Diseases | 1 | 2016 | 11 | 0.560 |
Why?
|
| Heparin | 1 | 2017 | 73 | 0.560 |
Why?
|
| Arteriosclerosis | 5 | 2005 | 123 | 0.560 |
Why?
|
| DNA-Binding Proteins | 9 | 2020 | 147 | 0.550 |
Why?
|
| Anticoagulants | 1 | 2017 | 122 | 0.530 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 47 | 0.530 |
Why?
|
| Medicare | 1 | 2017 | 206 | 0.530 |
Why?
|
| Catheters, Indwelling | 2 | 2014 | 42 | 0.530 |
Why?
|
| Genetic Markers | 11 | 2016 | 124 | 0.520 |
Why?
|
| Health Services Accessibility | 3 | 2013 | 242 | 0.520 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 9 | 0.510 |
Why?
|
| Mesangial Cells | 2 | 2016 | 10 | 0.510 |
Why?
|
| Gene Dosage | 2 | 2013 | 35 | 0.510 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 873 | 0.510 |
Why?
|
| Logistic Models | 11 | 2017 | 783 | 0.510 |
Why?
|
| Diabetic Retinopathy | 5 | 2018 | 65 | 0.510 |
Why?
|
| Cyclosporins | 1 | 2015 | 22 | 0.500 |
Why?
|
| Graft Rejection | 2 | 2018 | 238 | 0.500 |
Why?
|
| Hippocampus | 1 | 2016 | 170 | 0.490 |
Why?
|
| Odds Ratio | 11 | 2017 | 472 | 0.490 |
Why?
|
| Mycophenolic Acid | 1 | 2015 | 41 | 0.490 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2014 | 40 | 0.490 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2014 | 23 | 0.480 |
Why?
|
| Dexamethasone | 1 | 2015 | 44 | 0.480 |
Why?
|
| Longitudinal Studies | 6 | 2018 | 770 | 0.480 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2018 | 67 | 0.470 |
Why?
|
| Genetics, Population | 2 | 2013 | 32 | 0.470 |
Why?
|
| Urinalysis | 2 | 2020 | 27 | 0.470 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 10 | 0.470 |
Why?
|
| Brain Diseases | 1 | 2014 | 38 | 0.470 |
Why?
|
| Pruritus | 4 | 2009 | 47 | 0.470 |
Why?
|
| Linear Models | 5 | 2017 | 448 | 0.470 |
Why?
|
| Neoplasm Proteins | 3 | 2013 | 148 | 0.470 |
Why?
|
| Cholesterol, HDL | 6 | 2019 | 177 | 0.460 |
Why?
|
| Adolescent | 19 | 2019 | 3568 | 0.460 |
Why?
|
| Autoantigens | 1 | 2013 | 16 | 0.460 |
Why?
|
| Complement C4 | 1 | 2013 | 4 | 0.450 |
Why?
|
| Hyperglycemia | 2 | 2013 | 84 | 0.440 |
Why?
|
| Dipeptidases | 3 | 2009 | 5 | 0.440 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2013 | 80 | 0.440 |
Why?
|
| Glycemic Index | 1 | 2013 | 14 | 0.440 |
Why?
|
| Hematuria | 1 | 2012 | 11 | 0.430 |
Why?
|
| Mice | 15 | 2019 | 2474 | 0.430 |
Why?
|
| Kidney Tubules | 3 | 2020 | 26 | 0.430 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2014 | 105 | 0.430 |
Why?
|
| Smoking | 6 | 2019 | 528 | 0.430 |
Why?
|
| Lactobacillus | 1 | 2012 | 14 | 0.430 |
Why?
|
| Calcium | 6 | 2012 | 306 | 0.420 |
Why?
|
| Prospective Studies | 9 | 2019 | 2282 | 0.420 |
Why?
|
| Severity of Illness Index | 11 | 2019 | 881 | 0.420 |
Why?
|
| Chi-Square Distribution | 4 | 2016 | 297 | 0.420 |
Why?
|
| Insurance Coverage | 1 | 2013 | 75 | 0.420 |
Why?
|
| Demography | 4 | 2016 | 110 | 0.420 |
Why?
|
| Introns | 9 | 2014 | 39 | 0.410 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 29 | 0.410 |
Why?
|
| Population Surveillance | 2 | 2012 | 125 | 0.410 |
Why?
|
| Attitude to Health | 1 | 2013 | 166 | 0.400 |
Why?
|
| Blood Chemical Analysis | 1 | 2011 | 22 | 0.400 |
Why?
|
| Metabolism | 1 | 2011 | 7 | 0.390 |
Why?
|
| Hemoglobin, Sickle | 1 | 2011 | 8 | 0.390 |
Why?
|
| Lod Score | 8 | 2016 | 72 | 0.390 |
Why?
|
| Environmental Exposure | 1 | 2012 | 91 | 0.390 |
Why?
|
| Family | 5 | 2015 | 117 | 0.380 |
Why?
|
| Length of Stay | 1 | 2012 | 312 | 0.380 |
Why?
|
| HIV Infections | 2 | 2014 | 395 | 0.370 |
Why?
|
| Survival Analysis | 5 | 2018 | 483 | 0.370 |
Why?
|
| Antibodies, Antinuclear | 3 | 2016 | 18 | 0.360 |
Why?
|
| Complement C1q | 1 | 2010 | 4 | 0.350 |
Why?
|
| Dementia | 3 | 2020 | 253 | 0.350 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2010 | 35 | 0.350 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2009 | 18 | 0.340 |
Why?
|
| Environment | 1 | 2010 | 54 | 0.340 |
Why?
|
| Asian Continental Ancestry Group | 12 | 2019 | 108 | 0.340 |
Why?
|
| Erythropoiesis | 1 | 2009 | 7 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 22 | 4 | 2011 | 20 | 0.340 |
Why?
|
| Podocytes | 4 | 2018 | 20 | 0.340 |
Why?
|
| Hematinics | 1 | 2009 | 6 | 0.340 |
Why?
|
| Cause of Death | 5 | 2017 | 236 | 0.340 |
Why?
|
| Liver | 3 | 2019 | 484 | 0.340 |
Why?
|
| Retrospective Studies | 9 | 2018 | 3505 | 0.330 |
Why?
|
| Europe | 6 | 2021 | 82 | 0.330 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2020 | 510 | 0.330 |
Why?
|
| Blood Vessels | 1 | 2009 | 48 | 0.330 |
Why?
|
| Vitamin D Deficiency | 3 | 2018 | 89 | 0.330 |
Why?
|
| Biomedical Research | 3 | 2016 | 156 | 0.330 |
Why?
|
| Promoter Regions, Genetic | 7 | 2014 | 208 | 0.330 |
Why?
|
| Anemia | 1 | 2009 | 58 | 0.330 |
Why?
|
| P-Selectin | 2 | 2005 | 10 | 0.330 |
Why?
|
| Placentation | 1 | 2008 | 4 | 0.320 |
Why?
|
| Alcohol Drinking | 3 | 2019 | 255 | 0.320 |
Why?
|
| Residence Characteristics | 2 | 2012 | 202 | 0.320 |
Why?
|
| Chronic Disease | 5 | 2015 | 406 | 0.320 |
Why?
|
| Ephrin-B2 | 1 | 2008 | 2 | 0.320 |
Why?
|
| TCF Transcription Factors | 2 | 2008 | 8 | 0.320 |
Why?
|
| Triglycerides | 4 | 2019 | 230 | 0.310 |
Why?
|
| Nitric Oxide Synthase | 2 | 2005 | 35 | 0.310 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2018 | 22 | 0.310 |
Why?
|
| Tunica Intima | 4 | 2013 | 57 | 0.310 |
Why?
|
| Systole | 5 | 2019 | 99 | 0.310 |
Why?
|
| Placenta | 1 | 2008 | 74 | 0.300 |
Why?
|
| Veins | 1 | 2008 | 29 | 0.300 |
Why?
|
| Arteriovenous Fistula | 1 | 2008 | 18 | 0.300 |
Why?
|
| Vascular Patency | 1 | 2008 | 69 | 0.300 |
Why?
|
| Comorbidity | 7 | 2016 | 566 | 0.300 |
Why?
|
| Chromosomes, Human, X | 2 | 2021 | 12 | 0.300 |
Why?
|
| Reference Values | 9 | 2016 | 246 | 0.300 |
Why?
|
| Enterococcus | 1 | 2007 | 11 | 0.290 |
Why?
|
| Vancomycin Resistance | 1 | 2007 | 8 | 0.290 |
Why?
|
| Biopsy | 4 | 2014 | 259 | 0.290 |
Why?
|
| Nephrology | 3 | 2014 | 33 | 0.290 |
Why?
|
| Carotid Arteries | 4 | 2015 | 99 | 0.290 |
Why?
|
| Methicillin Resistance | 1 | 2007 | 22 | 0.290 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 56 | 0.290 |
Why?
|
| Trinucleotide Repeats | 1 | 2007 | 9 | 0.280 |
Why?
|
| STAT1 Transcription Factor | 2 | 2018 | 12 | 0.280 |
Why?
|
| Leucine | 1 | 2007 | 20 | 0.280 |
Why?
|
| Thrombosis | 1 | 2007 | 73 | 0.280 |
Why?
|
| Staphylococcus aureus | 1 | 2007 | 53 | 0.280 |
Why?
|
| Age Factors | 6 | 2016 | 1187 | 0.280 |
Why?
|
| Transcription Factors | 5 | 2019 | 181 | 0.280 |
Why?
|
| Cluster Analysis | 3 | 2014 | 125 | 0.280 |
Why?
|
| Salvage Therapy | 1 | 2007 | 134 | 0.280 |
Why?
|
| Muscles | 2 | 2018 | 62 | 0.280 |
Why?
|
| Genome | 4 | 2020 | 38 | 0.280 |
Why?
|
| Sex Characteristics | 5 | 2016 | 173 | 0.280 |
Why?
|
| Sex Distribution | 6 | 2016 | 191 | 0.280 |
Why?
|
| Meta-Analysis as Topic | 4 | 2019 | 43 | 0.270 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 77 | 0.270 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 31 | 0.270 |
Why?
|
| Nephrectomy | 2 | 2020 | 123 | 0.270 |
Why?
|
| Exons | 6 | 2014 | 52 | 0.260 |
Why?
|
| Hepatocytes | 2 | 2017 | 76 | 0.260 |
Why?
|
| Heterozygote | 2 | 2016 | 59 | 0.260 |
Why?
|
| Cholesterol, LDL | 4 | 2020 | 173 | 0.260 |
Why?
|
| Phosphates | 2 | 2015 | 25 | 0.250 |
Why?
|
| Renal Artery | 2 | 2004 | 47 | 0.250 |
Why?
|
| Sex Factors | 6 | 2017 | 667 | 0.250 |
Why?
|
| Tacrolimus | 1 | 2005 | 65 | 0.240 |
Why?
|
| Quality of Life | 2 | 2017 | 946 | 0.240 |
Why?
|
| Cells, Cultured | 3 | 2016 | 827 | 0.240 |
Why?
|
| Tunica Media | 2 | 2013 | 28 | 0.240 |
Why?
|
| Signal Transduction | 3 | 2017 | 680 | 0.230 |
Why?
|
| Fasting | 3 | 2017 | 95 | 0.230 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
| Myocardial Infarction | 6 | 2017 | 473 | 0.220 |
Why?
|
| Interferon Regulatory Factors | 2 | 2014 | 13 | 0.220 |
Why?
|
| Age Distribution | 5 | 2016 | 206 | 0.220 |
Why?
|
| Radiography | 3 | 2015 | 374 | 0.220 |
Why?
|
| Pesticides | 1 | 2016 | 199 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2010 | 15 | 0.220 |
Why?
|
| Electrocardiography | 7 | 2014 | 604 | 0.220 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 240 | 0.220 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2014 | 23 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2016 | 232 | 0.220 |
Why?
|
| Complement Factor H | 2 | 2014 | 5 | 0.210 |
Why?
|
| Birth Weight | 1 | 2003 | 47 | 0.210 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2014 | 12 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2008 | 19 | 0.210 |
Why?
|
| Age of Onset | 6 | 2017 | 94 | 0.210 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2019 | 47 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2019 | 443 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2002 | 8 | 0.210 |
Why?
|
| Nuclear Family | 1 | 2002 | 15 | 0.210 |
Why?
|
| DNA Mutational Analysis | 3 | 2018 | 72 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 244 | 0.210 |
Why?
|
| Transplantation, Homologous | 2 | 2020 | 151 | 0.210 |
Why?
|
| Glomerular Basement Membrane | 2 | 2019 | 4 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 297 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 198 | 0.210 |
Why?
|
| Terminology as Topic | 2 | 2015 | 65 | 0.210 |
Why?
|
| American Native Continental Ancestry Group | 3 | 2017 | 13 | 0.200 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2014 | 9 | 0.200 |
Why?
|
| Bone Morphogenetic Protein 4 | 2 | 2013 | 13 | 0.200 |
Why?
|
| Chromogranin A | 2 | 2014 | 3 | 0.200 |
Why?
|
| Urologic Diseases | 2 | 2013 | 27 | 0.200 |
Why?
|
| Homozygote | 3 | 2019 | 58 | 0.200 |
Why?
|
| Exercise | 3 | 2019 | 672 | 0.200 |
Why?
|
| Actinin | 2 | 2012 | 4 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2014 | 180 | 0.190 |
Why?
|
| Intra-Abdominal Fat | 2 | 2013 | 63 | 0.190 |
Why?
|
| Thoracic Vertebrae | 2 | 2018 | 42 | 0.190 |
Why?
|
| Databases, Factual | 3 | 2009 | 354 | 0.190 |
Why?
|
| Body Height | 1 | 2021 | 34 | 0.190 |
Why?
|
| Body Composition | 2 | 2018 | 396 | 0.180 |
Why?
|
| Sensitivity and Specificity | 4 | 2011 | 581 | 0.180 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 261 | 0.180 |
Why?
|
| Coronary Angiography | 2 | 2018 | 153 | 0.180 |
Why?
|
| Lumbar Vertebrae | 2 | 2018 | 101 | 0.180 |
Why?
|
| Early Diagnosis | 2 | 2012 | 62 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 8 | 2015 | 137 | 0.180 |
Why?
|
| Interleukin-18 | 1 | 2020 | 9 | 0.180 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 322 | 0.180 |
Why?
|
| Consanguinity | 1 | 2019 | 1 | 0.170 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 8 | 0.170 |
Why?
|
| Gastroparesis | 1 | 2019 | 10 | 0.170 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2020 | 35 | 0.170 |
Why?
|
| Disease Susceptibility | 3 | 2005 | 57 | 0.170 |
Why?
|
| Body Size | 1 | 2019 | 34 | 0.170 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 77 | 0.170 |
Why?
|
| Treatment Failure | 2 | 2012 | 162 | 0.170 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 24 | 0.170 |
Why?
|
| Zebrafish | 3 | 2018 | 23 | 0.170 |
Why?
|
| Morbidity | 2 | 2018 | 98 | 0.170 |
Why?
|
| Repressor Proteins | 1 | 2019 | 50 | 0.170 |
Why?
|
| Fertility | 1 | 2019 | 31 | 0.170 |
Why?
|
| Heredity | 2 | 2012 | 13 | 0.170 |
Why?
|
| Perfusion | 1 | 2019 | 73 | 0.170 |
Why?
|
| Genetic Heterogeneity | 2 | 2013 | 14 | 0.170 |
Why?
|
| Transcription, Genetic | 3 | 2018 | 137 | 0.170 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2019 | 63 | 0.170 |
Why?
|
| Sphingosine | 1 | 2019 | 13 | 0.170 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 512 | 0.170 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 357 | 0.170 |
Why?
|
| RNA | 1 | 2020 | 92 | 0.170 |
Why?
|
| Lysophospholipids | 1 | 2019 | 24 | 0.170 |
Why?
|
| Regression Analysis | 4 | 2019 | 292 | 0.170 |
Why?
|
| Mortality | 2 | 2017 | 125 | 0.160 |
Why?
|
| Cholesterol | 2 | 2019 | 252 | 0.160 |
Why?
|
| Muscle Contraction | 1 | 2019 | 112 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2009 | 7 | 0.160 |
Why?
|
| Risk-Taking | 1 | 2019 | 96 | 0.160 |
Why?
|
| Health Policy | 1 | 2019 | 89 | 0.160 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2018 | 11 | 0.160 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2018 | 5 | 0.160 |
Why?
|
| Virus Replication | 1 | 2019 | 42 | 0.160 |
Why?
|
| Hemodynamics | 1 | 2019 | 155 | 0.160 |
Why?
|
| STAT4 Transcription Factor | 1 | 2018 | 15 | 0.160 |
Why?
|
| Mexican Americans | 2 | 2016 | 60 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 407 | 0.160 |
Why?
|
| Survival Rate | 4 | 2019 | 876 | 0.160 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2018 | 4 | 0.160 |
Why?
|
| Antigens, CD | 2 | 2008 | 103 | 0.160 |
Why?
|
| Models, Biological | 2 | 2011 | 392 | 0.160 |
Why?
|
| Mutation, Missense | 2 | 2018 | 50 | 0.150 |
Why?
|
| Collagen | 1 | 2019 | 225 | 0.150 |
Why?
|
| Principal Component Analysis | 3 | 2017 | 68 | 0.150 |
Why?
|
| Healthcare Disparities | 2 | 2019 | 169 | 0.150 |
Why?
|
| Long QT Syndrome | 2 | 2009 | 43 | 0.150 |
Why?
|
| Resource Allocation | 1 | 2017 | 9 | 0.150 |
Why?
|
| Radius | 1 | 2017 | 26 | 0.150 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 66 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 225 | 0.150 |
Why?
|
| Health Status Indicators | 1 | 2018 | 73 | 0.150 |
Why?
|
| Genetic Load | 1 | 2017 | 4 | 0.150 |
Why?
|
| Aorta, Abdominal | 2 | 2007 | 29 | 0.150 |
Why?
|
| Energy Metabolism | 1 | 2018 | 147 | 0.150 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2017 | 7 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 2 | 2008 | 52 | 0.150 |
Why?
|
| Ultrafiltration | 1 | 2017 | 11 | 0.150 |
Why?
|
| Pregnancy | 2 | 2012 | 996 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2017 | 20 | 0.140 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 20 | 0.140 |
Why?
|
| Lipogenesis | 1 | 2017 | 18 | 0.140 |
Why?
|
| HLA Antigens | 1 | 2017 | 40 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 299 | 0.140 |
Why?
|
| Mitochondria | 1 | 2018 | 185 | 0.140 |
Why?
|
| Health Status | 1 | 2019 | 400 | 0.140 |
Why?
|
| Hypotension | 1 | 2017 | 47 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 68 | 0.140 |
Why?
|
| Siblings | 4 | 2011 | 25 | 0.140 |
Why?
|
| Educational Status | 3 | 2015 | 181 | 0.140 |
Why?
|
| Albumins | 2 | 2014 | 45 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2006 | 13 | 0.140 |
Why?
|
| Waist Circumference | 1 | 2016 | 90 | 0.140 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2016 | 4 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 104 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2013 | 9 | 0.130 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2016 | 5 | 0.130 |
Why?
|
| Multigene Family | 2 | 2013 | 51 | 0.130 |
Why?
|
| Epithelial Cells | 2 | 2014 | 141 | 0.130 |
Why?
|
| Autonomic Nervous System | 1 | 2016 | 43 | 0.130 |
Why?
|
| Hormone Replacement Therapy | 2 | 2007 | 91 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 764 | 0.130 |
Why?
|
| Iliac Artery | 1 | 2015 | 49 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2006 | 17 | 0.130 |
Why?
|
| Cell Line | 2 | 2014 | 435 | 0.130 |
Why?
|
| Therapies, Investigational | 1 | 2015 | 4 | 0.130 |
Why?
|
| Renal Replacement Therapy | 1 | 2015 | 18 | 0.130 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2015 | 4 | 0.130 |
Why?
|
| Leptin | 1 | 2015 | 71 | 0.130 |
Why?
|
| Foot | 1 | 2015 | 39 | 0.130 |
Why?
|
| Lipoproteins, LDL | 1 | 2015 | 81 | 0.120 |
Why?
|
| Aorta | 2 | 2019 | 126 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2016 | 179 | 0.120 |
Why?
|
| Hand | 1 | 2015 | 66 | 0.120 |
Why?
|
| Spectrin | 1 | 2014 | 5 | 0.120 |
Why?
|
| Health Status Disparities | 2 | 2019 | 131 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 60 | 0.120 |
Why?
|
| Gene Expression | 3 | 2011 | 337 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2016 | 136 | 0.120 |
Why?
|
| Stroop Test | 1 | 2014 | 5 | 0.120 |
Why?
|
| Protein Binding | 4 | 2018 | 201 | 0.120 |
Why?
|
| Zebrafish Proteins | 1 | 2014 | 3 | 0.120 |
Why?
|
| Norway | 1 | 2014 | 7 | 0.120 |
Why?
|
| Coronary Disease | 2 | 2006 | 211 | 0.120 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2014 | 4 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2015 | 66 | 0.120 |
Why?
|
| Memory | 1 | 2016 | 190 | 0.120 |
Why?
|
| beta Karyopherins | 1 | 2014 | 6 | 0.120 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2014 | 5 | 0.120 |
Why?
|
| Receptors, Complement 3d | 1 | 2014 | 12 | 0.120 |
Why?
|
| HLA-B27 Antigen | 1 | 2014 | 8 | 0.120 |
Why?
|
| HMGA2 Protein | 1 | 2014 | 13 | 0.120 |
Why?
|
| Arachidonic Acid | 2 | 2011 | 35 | 0.120 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 53 | 0.120 |
Why?
|
| Atrophy | 1 | 2014 | 46 | 0.120 |
Why?
|
| Muscle Proteins | 2 | 2019 | 59 | 0.120 |
Why?
|
| Calcium, Dietary | 1 | 2014 | 23 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2020 | 780 | 0.120 |
Why?
|
| Glucuronidase | 2 | 2014 | 12 | 0.120 |
Why?
|
| Phosphoproteins | 2 | 2005 | 49 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2011 | 24 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 88 | 0.120 |
Why?
|
| Wnt1 Protein | 1 | 2014 | 3 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2014 | 16 | 0.120 |
Why?
|
| Africa | 3 | 2021 | 27 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 179 | 0.120 |
Why?
|
| Postmenopause | 2 | 2007 | 430 | 0.120 |
Why?
|
| Open Reading Frames | 1 | 2014 | 20 | 0.120 |
Why?
|
| Anxiety | 1 | 2015 | 191 | 0.110 |
Why?
|
| Trypanosomiasis, African | 2 | 2010 | 6 | 0.110 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2013 | 3 | 0.110 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2013 | 6 | 0.110 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2013 | 15 | 0.110 |
Why?
|
| Double-Blind Method | 4 | 2014 | 525 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2013 | 4 | 0.110 |
Why?
|
| Founder Effect | 1 | 2013 | 5 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2013 | 30 | 0.110 |
Why?
|
| OX40 Ligand | 1 | 2013 | 6 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 155 | 0.110 |
Why?
|
| Absorptiometry, Photon | 3 | 2017 | 143 | 0.110 |
Why?
|
| Interleukin-1 | 2 | 2003 | 33 | 0.110 |
Why?
|
| Glucuronosyltransferase | 1 | 2013 | 5 | 0.110 |
Why?
|
| Immune Complex Diseases | 1 | 2013 | 2 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2014 | 115 | 0.110 |
Why?
|
| Cystatin C | 1 | 2013 | 31 | 0.110 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 51 | 0.110 |
Why?
|
| Dopamine | 1 | 2016 | 232 | 0.110 |
Why?
|
| Bone Resorption | 1 | 2013 | 12 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2015 | 161 | 0.110 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2013 | 9 | 0.110 |
Why?
|
| Haptoglobins | 1 | 2013 | 4 | 0.110 |
Why?
|
| Carotid Artery, Common | 2 | 2004 | 39 | 0.110 |
Why?
|
| Stroke Volume | 2 | 2013 | 348 | 0.110 |
Why?
|
| DNA, Viral | 1 | 2013 | 54 | 0.110 |
Why?
|
| Bilirubin | 1 | 2013 | 25 | 0.110 |
Why?
|
| Tomography, Spiral Computed | 1 | 2013 | 19 | 0.110 |
Why?
|
| Reagent Strips | 1 | 2012 | 4 | 0.110 |
Why?
|
| Selenoproteins | 1 | 2012 | 3 | 0.110 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2013 | 28 | 0.110 |
Why?
|
| Osmolar Concentration | 1 | 2012 | 21 | 0.110 |
Why?
|
| Diet | 2 | 2013 | 390 | 0.110 |
Why?
|
| Dietary Supplements | 1 | 2014 | 185 | 0.110 |
Why?
|
| False Positive Reactions | 1 | 2012 | 29 | 0.110 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2012 | 2 | 0.110 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2012 | 14 | 0.110 |
Why?
|
| Autoantibodies | 2 | 2013 | 49 | 0.100 |
Why?
|
| 3' Untranslated Regions | 5 | 2014 | 24 | 0.100 |
Why?
|
| Inflammation | 2 | 2013 | 529 | 0.100 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 8 | 0.100 |
Why?
|
| Egg Proteins | 1 | 2012 | 2 | 0.100 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 2 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 1020 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 170 | 0.100 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2012 | 10 | 0.100 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2012 | 4 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 43 | 0.100 |
Why?
|
| Depression | 1 | 2015 | 445 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2013 | 135 | 0.100 |
Why?
|
| Insulin-Secreting Cells | 2 | 2017 | 53 | 0.100 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 5 | 0.100 |
Why?
|
| Heart Rate | 1 | 2014 | 335 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2014 | 89 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 105 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 172 | 0.100 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2011 | 14 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2014 | 14 | 0.100 |
Why?
|
| Health Services for the Aged | 1 | 2011 | 25 | 0.100 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2011 | 30 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 135 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 45 | 0.090 |
Why?
|
| Base Sequence | 5 | 2012 | 252 | 0.090 |
Why?
|
| Acute Coronary Syndrome | 3 | 2017 | 194 | 0.090 |
Why?
|
| Fatty Acid Desaturases | 1 | 2011 | 48 | 0.090 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2010 | 18 | 0.090 |
Why?
|
| Apolipoprotein A-I | 1 | 2011 | 68 | 0.090 |
Why?
|
| Phosphorus | 1 | 2010 | 10 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 75 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Trypanosoma brucei rhodesiense | 1 | 2010 | 2 | 0.090 |
Why?
|
| Endocrine System Diseases | 1 | 2010 | 4 | 0.090 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2010 | 3 | 0.090 |
Why?
|
| Japan | 1 | 2010 | 17 | 0.090 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 283 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2010 | 23 | 0.090 |
Why?
|
| China | 1 | 2010 | 50 | 0.090 |
Why?
|
| Isoenzymes | 1 | 2010 | 61 | 0.090 |
Why?
|
| Nephrotic Syndrome | 1 | 2010 | 13 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2010 | 98 | 0.090 |
Why?
|
| Mucoproteins | 1 | 2010 | 13 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2009 | 10 | 0.090 |
Why?
|
| ROC Curve | 3 | 2018 | 163 | 0.090 |
Why?
|
| Censuses | 1 | 2009 | 10 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2009 | 20 | 0.090 |
Why?
|
| Geography | 1 | 2009 | 35 | 0.090 |
Why?
|
| Peritoneal Dialysis | 1 | 2010 | 26 | 0.090 |
Why?
|
| Family Characteristics | 1 | 2009 | 36 | 0.080 |
Why?
|
| Hemoglobins | 1 | 2009 | 49 | 0.080 |
Why?
|
| Forecasting | 1 | 2010 | 142 | 0.080 |
Why?
|
| Social Class | 1 | 2009 | 90 | 0.080 |
Why?
|
| Southeastern United States | 2 | 2008 | 79 | 0.080 |
Why?
|
| Propylene Glycols | 1 | 2009 | 2 | 0.080 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2009 | 2 | 0.080 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2009 | 3 | 0.080 |
Why?
|
| Apyrase | 1 | 2008 | 2 | 0.080 |
Why?
|
| Life Style | 3 | 2019 | 408 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2009 | 15 | 0.080 |
Why?
|
| Serum Amyloid P-Component | 1 | 2008 | 3 | 0.080 |
Why?
|
| Galectins | 1 | 2008 | 6 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 157 | 0.080 |
Why?
|
| Angiogenic Proteins | 1 | 2008 | 10 | 0.080 |
Why?
|
| Pregnancy Proteins | 1 | 2008 | 13 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 765 | 0.080 |
Why?
|
| TRPC Cation Channels | 1 | 2008 | 2 | 0.080 |
Why?
|
| Morpholines | 1 | 2009 | 37 | 0.080 |
Why?
|
| Sequence Deletion | 3 | 2017 | 40 | 0.080 |
Why?
|
| Rats | 4 | 2015 | 1592 | 0.080 |
Why?
|
| Administration, Topical | 2 | 2009 | 139 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 181 | 0.080 |
Why?
|
| Epoxide Hydrolases | 1 | 2008 | 4 | 0.080 |
Why?
|
| Asian Americans | 3 | 2013 | 97 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 48 | 0.080 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2008 | 6 | 0.080 |
Why?
|
| Intraocular Pressure | 2 | 2018 | 40 | 0.080 |
Why?
|
| Pyrophosphatases | 1 | 2008 | 3 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2008 | 66 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 82 | 0.080 |
Why?
|
| Diabetic Neuropathies | 1 | 2007 | 24 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2007 | 28 | 0.070 |
Why?
|
| Brachiocephalic Veins | 1 | 2007 | 8 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 42 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2018 | 57 | 0.070 |
Why?
|
| Proprotein Convertase 2 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Radial Artery | 1 | 2007 | 16 | 0.070 |
Why?
|
| Diastole | 2 | 2018 | 96 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2017 | 66 | 0.070 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2020 | 16 | 0.070 |
Why?
|
| Causality | 1 | 2007 | 38 | 0.070 |
Why?
|
| Angiography | 1 | 2007 | 80 | 0.070 |
Why?
|
| Infection Control | 1 | 2007 | 28 | 0.070 |
Why?
|
| Carnosine | 1 | 2007 | 3 | 0.070 |
Why?
|
| Interdisciplinary Communication | 2 | 2019 | 58 | 0.070 |
Why?
|
| Proline | 1 | 2006 | 12 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2006 | 19 | 0.070 |
Why?
|
| Lymphotoxin-alpha | 1 | 2006 | 4 | 0.070 |
Why?
|
| Ultrasonography | 3 | 2006 | 378 | 0.070 |
Why?
|
| Urban Population | 1 | 2007 | 89 | 0.070 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2007 | 132 | 0.070 |
Why?
|
| Trans-Activators | 1 | 2006 | 46 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 51 | 0.070 |
Why?
|
| CD40 Ligand | 1 | 2006 | 12 | 0.070 |
Why?
|
| Estrogens | 1 | 2007 | 180 | 0.070 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2005 | 2 | 0.070 |
Why?
|
| Endothelium | 1 | 2005 | 7 | 0.070 |
Why?
|
| Receptors, Opioid, mu | 1 | 2005 | 31 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 629 | 0.060 |
Why?
|
| Threonine | 1 | 2005 | 9 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 2005 | 12 | 0.060 |
Why?
|
| Skin | 1 | 2007 | 211 | 0.060 |
Why?
|
| Uremia | 1 | 2005 | 9 | 0.060 |
Why?
|
| Ointments | 1 | 2005 | 24 | 0.060 |
Why?
|
| Chemokines, CC | 1 | 2005 | 5 | 0.060 |
Why?
|
| Gene Duplication | 1 | 2005 | 5 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 36 | 0.060 |
Why?
|
| HIV-1 | 1 | 2005 | 45 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2005 | 47 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2015 | 80 | 0.060 |
Why?
|
| Health Priorities | 2 | 2014 | 15 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2005 | 164 | 0.060 |
Why?
|
| Guanidines | 1 | 2003 | 6 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2016 | 160 | 0.060 |
Why?
|
| Cysteine | 1 | 2005 | 138 | 0.060 |
Why?
|
| Databases, Genetic | 2 | 2014 | 37 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2003 | 8 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2003 | 30 | 0.060 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2003 | 6 | 0.060 |
Why?
|
| Birth Certificates | 1 | 2003 | 4 | 0.050 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 276 | 0.050 |
Why?
|
| South Carolina | 1 | 2003 | 31 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2013 | 81 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 164 | 0.050 |
Why?
|
| DNA Primers | 3 | 2008 | 91 | 0.050 |
Why?
|
| Waist-Hip Ratio | 2 | 2017 | 34 | 0.050 |
Why?
|
| Child | 3 | 2018 | 2439 | 0.050 |
Why?
|
| Tissue Kallikreins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Hypertension, Renovascular | 1 | 2002 | 15 | 0.050 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 68 | 0.050 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 2 | 2011 | 13 | 0.050 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 6 | 0.050 |
Why?
|
| Minisatellite Repeats | 2 | 2016 | 9 | 0.050 |
Why?
|
| Heart Failure | 2 | 2017 | 639 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2021 | 34 | 0.050 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 2 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 18 | 0.050 |
Why?
|
| tRNA Methyltransferases | 2 | 2012 | 5 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 5 | 2 | 2012 | 6 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 85 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 100 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 5 | 0.040 |
Why?
|
| Delayed Graft Function | 1 | 2020 | 33 | 0.040 |
Why?
|
| Washington | 1 | 2019 | 7 | 0.040 |
Why?
|
| Mississippi | 1 | 2019 | 27 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 5 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2019 | 41 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2019 | 11 | 0.040 |
Why?
|
| Tennessee | 1 | 2019 | 102 | 0.040 |
Why?
|
| BK Virus | 1 | 2019 | 6 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2020 | 62 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2020 | 220 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 16 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2011 | 38 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 42 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 35 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 45 | 0.040 |
Why?
|
| Fibrosis | 1 | 2019 | 120 | 0.040 |
Why?
|
| Probability | 2 | 2009 | 159 | 0.040 |
Why?
|
| Community-Based Participatory Research | 1 | 2019 | 115 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 317 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 725 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 105 | 0.040 |
Why?
|
| Body Constitution | 1 | 2018 | 25 | 0.040 |
Why?
|
| Selection, Genetic | 2 | 2010 | 8 | 0.040 |
Why?
|
| Visual Fields | 1 | 2018 | 27 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2017 | 11 | 0.040 |
Why?
|
| Reference Standards | 1 | 2017 | 32 | 0.040 |
Why?
|
| Femur Neck | 1 | 2017 | 21 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2017 | 7 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 15 | 0.040 |
Why?
|
| Patient Selection | 2 | 2011 | 276 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2017 | 41 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2018 | 73 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2017 | 21 | 0.040 |
Why?
|
| Finland | 1 | 2017 | 2 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 52 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2018 | 108 | 0.040 |
Why?
|
| Aging | 2 | 2016 | 943 | 0.040 |
Why?
|
| Anthropometry | 1 | 2017 | 83 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2009 | 462 | 0.040 |
Why?
|
| Kidney Tubules, Distal | 1 | 2016 | 3 | 0.030 |
Why?
|
| Critical Care | 1 | 2017 | 105 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 14 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 148 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 15 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2009 | 129 | 0.030 |
Why?
|
| Computational Biology | 1 | 2017 | 91 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 38 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2016 | 48 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 429 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2016 | 76 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 126 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 315 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2006 | 18 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 97 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 19 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 77 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2015 | 32 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2015 | 45 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2016 | 97 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2014 | 6 | 0.030 |
Why?
|
| Proteomics | 1 | 2015 | 93 | 0.030 |
Why?
|
| Autophagy | 1 | 2015 | 52 | 0.030 |
Why?
|
| Animals, Congenic | 1 | 2014 | 14 | 0.030 |
Why?
|
| Luciferases | 1 | 2014 | 32 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2005 | 3 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 32 | 0.030 |
Why?
|
| Receptors, Complement 3b | 1 | 2014 | 8 | 0.030 |
Why?
|
| Plasmids | 1 | 2014 | 48 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2014 | 74 | 0.030 |
Why?
|
| International Cooperation | 1 | 2014 | 28 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 66 | 0.030 |
Why?
|
| HLA-DR2 Antigen | 1 | 2014 | 3 | 0.030 |
Why?
|
| HLA-DR3 Antigen | 1 | 2014 | 3 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2014 | 34 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2014 | 30 | 0.030 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2014 | 18 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 48 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2014 | 18 | 0.030 |
Why?
|
| Lanthanum | 1 | 2014 | 3 | 0.030 |
Why?
|
| Phosphorus, Dietary | 1 | 2014 | 3 | 0.030 |
Why?
|
| Career Choice | 1 | 2014 | 43 | 0.030 |
Why?
|
| Angiotensinogen | 1 | 2014 | 59 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2014 | 23 | 0.030 |
Why?
|
| Brugada Syndrome | 1 | 2014 | 17 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 81 | 0.030 |
Why?
|
| Education, Medical | 1 | 2014 | 69 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2014 | 45 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2013 | 5 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 261 | 0.030 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2013 | 5 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 59 | 0.030 |
Why?
|
| Receptors, Adiponectin | 1 | 2013 | 3 | 0.030 |
Why?
|
| NADH Dehydrogenase | 1 | 2013 | 4 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 90 | 0.030 |
Why?
|
| Muramidase | 1 | 2013 | 8 | 0.030 |
Why?
|
| Glutathione Reductase | 1 | 2013 | 9 | 0.030 |
Why?
|
| Heart Conduction System | 1 | 2014 | 72 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2013 | 17 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2013 | 7 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2013 | 57 | 0.030 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2013 | 18 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2013 | 189 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 18 | 0.030 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2012 | 1 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 122 | 0.030 |
Why?
|
| Inhibin-beta Subunits | 1 | 2012 | 2 | 0.030 |
Why?
|
| Echocardiography | 1 | 2013 | 158 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 496 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 77 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2012 | 4 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2012 | 7 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2012 | 8 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 74 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 41 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2012 | 13 | 0.030 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 7 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 77 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 13 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2011 | 30 | 0.020 |
Why?
|
| Oral Ulcer | 1 | 2011 | 5 | 0.020 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2011 | 7 | 0.020 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 29 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2011 | 16 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 20 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 353 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 124 | 0.020 |
Why?
|
| Americas | 1 | 2010 | 6 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2011 | 120 | 0.020 |
Why?
|
| Base Pairing | 1 | 2010 | 4 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 8 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2010 | 38 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2010 | 21 | 0.020 |
Why?
|
| Population Groups | 1 | 2009 | 7 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2010 | 75 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 247 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 268 | 0.020 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2010 | 50 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 107 | 0.020 |
Why?
|
| Emollients | 1 | 2009 | 11 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 246 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2009 | 98 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2008 | 16 | 0.020 |
Why?
|
| Microcirculation | 1 | 2008 | 65 | 0.020 |
Why?
|
| Cation Transport Proteins | 1 | 2008 | 24 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2008 | 31 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2008 | 8 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2008 | 27 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 94 | 0.020 |
Why?
|
| Genomics | 1 | 2008 | 85 | 0.020 |
Why?
|
| Permeability | 1 | 2007 | 9 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2008 | 175 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2009 | 349 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 152 | 0.020 |
Why?
|
| Ligands | 1 | 2007 | 81 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 240 | 0.020 |
Why?
|
| Hong Kong | 1 | 2005 | 2 | 0.020 |
Why?
|
| Viscera | 1 | 2005 | 17 | 0.020 |
Why?
|
| Receptors, CCR5 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2005 | 7 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2004 | 13 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 398 | 0.020 |
Why?
|
| Progesterone | 1 | 2005 | 101 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 2005 | 39 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2005 | 70 | 0.010 |
Why?
|
| Energy Intake | 1 | 2005 | 128 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2004 | 3 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 132 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 156 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2004 | 20 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2004 | 30 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 34 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 62 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2005 | 199 | 0.010 |
Why?
|
| Public Health | 1 | 2005 | 89 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 2004 | 58 | 0.010 |
Why?
|
| Electrophoresis | 1 | 2003 | 8 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 39 | 0.010 |
Why?
|